A serious new hurdle for CRISPR: Edited cells might cause cancer, two studies find
(By Sharon Begley for STAT) Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease,
Read More(By Sharon Begley for STAT) Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease,
Read MoreA new approach to killing C. difficile, the most common hospital-acquired bacterial infection in the US, is called antisense therapy.
Read More(By Rob Stein for NPR) Doctors at the National Institutes of Health say they’ve apparently completely eradicated cancer from a
Read More(By Casey Ross for STAT) Immunotherapy is a source of great hope in cancer care. It has rescued some patients from
Read More(By Sara Kiley Watson for NPR) For many breast cancer patients, one of the most difficult treatment decisions is whether
Read MoreThe Food and Drug Administration is accepting proposals from developers aimed at encouraging the development of medical devices or with
Read More(By Thad Kresho for STAT) More than 200 health care deals representing $72.6 billion were announced in the first quarter
Read More(By Andrew Joseph for STAT) Researchers have devised a new way to get a sneak peek into what’s going on
Read MoreOne of the priorities this year for the FDA is advancing digital health technologies. FDA’s Center for Devices and Radiological
Read More(By Casey Ross for STAT) Doctors across the U.S. have begun doing what once seemed unthinkable in a litigious health
Read More